Cargando…
Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomide
The prognosis for patients with newly diagnosed malignant gliomas remains poor; however there have been some recent advances in treatment that have generated optimism. Medical management usually includes administration of corticosteroids to control peritumoral edema. Anticonvulsants are indicated fo...
Autores principales: | Gilbert, Mark R, Armstrong, Terri S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387286/ https://www.ncbi.nlm.nih.gov/pubmed/18516257 |
Ejemplares similares
-
Diagnosis and Management of Stroke in Adults with Primary Brain Tumor
por: Komlodi-Pasztor, Edina, et al.
Publicado: (2022) -
Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients
por: Guzauskas, Gregory F, et al.
Publicado: (2018) -
Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
por: Vieito, Maria, et al.
Publicado: (2022) -
Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
por: Faye, Mame Daro, et al.
Publicado: (2023) -
Temozolomide and oral etoposide in children with recurrent malignant brain tumors
por: Ruggiero, Antonio, et al.
Publicado: (2020)